TickerFactsScreenerDevelopers

Protalix BioTherapeutics, Inc. (PLX) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2009: $6.20M2010: $7.86M2011: $5.71M2012: $2.07M2013: $1.89M2014: $785.0K2015: $464.0K2016: $849.0K2017: $971.0K2018: $686.0K2019: $627.0K2020: $655.0K2021: $1.46M2022: $628.0K2023: $1.15M2024: $1.28M2025: $1.64M$1.64M
2009Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$1.64M+27.8%
2024$1.28M+11.6%
2023$1.15M+83.0%
2022$628.0K-57.0%
2021$1.46M+122.7%
2020$655.0K+4.5%
2019$627.0K-8.6%
2018$686.0K-29.4%
2017$971.0K+14.4%
2016$849.0K+83.0%
2015$464.0K-40.9%
2014$785.0K-58.5%
2013$1.89M-8.6%
2012$2.07M-63.8%
2011$5.71M-27.4%
2010$7.86M+26.8%
2009$6.20M—